Prosecution Insights
Last updated: May 29, 2026

Elanco Tiergesundheit AG

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
4
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (75%)
0
Easy (0%)
1
Unknown (25%)

Rejection Statute Mix

BucketCases
§103 only2 (50%)
§102 only1 (25%)
No statute on record1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
25% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEE, CHIHYI NMN 1 32.5% +62.8%
SONG, JIANFENG 1 56.1% +33.5%
RAMACHANDRAN, UMAMAHESWARI 1 54.5% +53.7%
STIGELL, THEODORE J 1 78.2% +14.7%

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18109410 MONENSIN LEVELS FOR MODERN DAIRY DIET RAMACHANDRAN, UMAMAHESWARI 99d overdue
18253061 N-(2,3-DIHYDRO-1,4-BENZOXAZIN-4-YL)-3-ISOPROPYL-7-(2,3,5-TRIFLUOROPHENYL)BENZO-THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS FOR THE TREATMENT OF HEARTWORM INFECTIONS LEE, CHIHYI NMN 60d overdue
18043868 CHEWABLE FORMULATIONS SONG, JIANFENG 14d
17795341 WINGED CAPSULE STIGELL, THEODORE J 29d

Top Art Units

Art UnitApps
1628 1
1613 1
1627 1
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18253061 N-(2,3-DIHYDRO-1,4-BENZOXAZIN-4-YL)-3-ISOPROPYL-7-(2,3,5-TRIFLUOROPHENYL)BENZO-THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS FOR THE TREATMENT OF HEARTWORM INFECTIONS LEE, CHIHYI NMN 1628 Other Non-Final OA 60d overdue Pending May 16, 2023
18043868 CHEWABLE FORMULATIONS SONG, JIANFENG 1613 §103 Non-Final OA 14d Pending Mar 02, 2023
18109410 MONENSIN LEVELS FOR MODERN DAIRY DIET RAMACHANDRAN, UMAMAHESWARI 1627 §103 Non-Final OA 99d overdue Pending Feb 14, 2023
17795341 WINGED CAPSULE STIGELL, THEODORE J 3783 §102 Non-Final OA 29d Pending Jul 26, 2022

Managing Elanco Tiergesundheit AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month